Zemaira
Generic name: Alpha 1-proteinase Inhibitor
Drug class:
Miscellaneous respiratory agents
Usage of Zemaira
Zemaira contain the protein alpha 1-proteinase, also called alpha 1-antitrypsin. This protein occurs naturally in the body and is important for preventing the breakdown of tissues in the lungs.
In people who lack the alpha 1-antitrypsin protein, breakdown of lung tissues can lead to emphysema (damage to the air sacs in the lungs).
Zemaira is used to treat alpha 1-antitrypsin deficiency in people who have symptoms of emphysema.
Alpha 1-antitrypsin deficiency is a genetic (inherited) disorder and Zemaira will not cure this condition.
Zemaira side effects
Get emergency medical help if you have signs of an allergic reaction to Zemaira: hives, rash; confusion, feeling light-headed; fast heartbeats, chest tightness, difficult breathing; swelling of your face, lips, tongue, or throat.
Your doctor may also prescribe epinephrine (Epi-Pen) to keep with you in case you ever have an allergic reaction to Zemaira.
Stop using Zemaira and call your doctor at once if you have:
You may feel faint during the injection. You may need to rest for a short time afterward.
Common Zemaira side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Zemaira
You should not use Zemaira if:
To make sure Zemaira is safe for you, tell your doctor if you have:
Tell your doctor if you are pregnant or breastfeeding.
Zemaira in not approved for use by anyone younger than 18 years old.
Zemaira is made from donated human plasma and may contain viruses or other infectious agents. Donated plasma is tested and treated to reduce the risk of contamination, but there is still a small possibility it could transmit disease. Ask your doctor about any possible risk.
Relate drugs
- Alpha 1-proteinase inhibitor
- Alpha-1 proteinase inhibitor human
- Aralast
- Aralast NP
- Dornase alfa
- Dornase alfa inhalation
- Genosyl
- Glassia
- Inomax
- INOmax inhalation gas
- Nitric oxide
- Nitric oxide inhalation gas
- Noxivent
- Prolastin
- Prolastin-C
- Pulmozyme
- Zemaira
How to use Zemaira
Usual Adult Dose for Alpha-1 Proteinase Inhibitor Deficiency:
60 mg/kg intravenously once a week Comments: -Dose ranging studies using efficacy endpoints have not been performed. Use: Chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to hereditary deficiency of Alpha 1-Proteinase Inhibitor (alpha 1-antitrypsin deficiency)
Warnings
You should not use Zemaira if you have ever had an allergic reaction to alpha 1-proteinase inhibitor, or if you have an IgA (immunoglobulin A) deficiency or antibody against IgA.
Zemaira must be mixed with a liquid (diluent) before given as an injection. If you are using the injections at home, be sure you understand how to properly prepare and store your medicine.
Call your doctor at once if you have a serious side effect such as fever, chills, body aches, flu symptoms, mouth sores, pain or burning when you urinate, wheezing, chest pain or tightness, trouble breathing, or vision changes. Zemaira is made from human plasma (part of the blood) which may contain viruses and other infectious agents. Donated plasma is tested and treated to reduce the risk of it containing infectious agents, but there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.
What other drugs will affect Zemaira
Other drugs may interact with alpha 1-proteinase inhibitor, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions